Genome-wide association study on genetic variations associated with treatment failure after intravesical bacillus Calmette–Guérin therapy for non-muscle invasive bladder cancer.

Masaki Shiota,Naohiro Fujimoto,Yoshiaki Yamamoto,Ario Takeuchi,Katsunori Tatsugami,Takeshi Uchiumi,Hideyasu Matsuyama,Masatoshi Eto

Genome-wide association study on genetic variations associated with treatment failure after intravesical bacillus Calmette–Guérin therapy for non-muscle invasive bladder cancer.

2020

Masaki Shiota
Naohiro Fujimoto
Yoshiaki Yamamoto
Ario Takeuchi
Katsunori Tatsugami
Takeshi Uchiumi
Hideyasu Matsuyama
Masatoshi Eto

e17000Background: Bacillus Calmette–Guerin (BCG) instillation is a key therapy to manage non-muscle invasive bladder cancer (NMIBC). However, intravesical BCG therapy fails in approximately half of...

Keywords:

Genetic variation
Oncology
Internal medicine
non muscle invasive
Bladder cancer
Genome-wide association study
Intravesical bacillus Calmette-Guerin
Pathology
treatment failure
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations